Cargando…
Inequalities in the omission of axillary dissection in sentinel lymph node positive patients in the Netherlands: Innovative hospitals are early adopters of a de‐escalating approach
During the last decade completion axillary lymph node dissection (cALND) was gradually omitted in sentinel lymph node positive (SLN+) breast cancer patients. However, adoption varies among hospitals. We analyzed factors associated with the omission of cALND in all Dutch SLN+ patients. As one of the...
Autores principales: | van Steenhoven, Julia E. C., van Maaren, Marissa C., Verreck, Eline E. F., Schipper, Robert J., Nieuwenhuijzen, Grard A. P., Kuijer, Anne, Siesling, Sabine, van Dalen, Thijs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108210/ https://www.ncbi.nlm.nih.gov/pubmed/36522834 http://dx.doi.org/10.1002/ijc.34400 |
Ejemplares similares
-
Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
por: Verreck, Eline E. F., et al.
Publicado: (2023) -
ASO Author Reflections: Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
por: Verreck, Eline, et al.
Publicado: (2023) -
The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer
por: van Steenhoven, J. E. C., et al.
Publicado: (2019) -
Quantifying the Mitigating Effects of Whole-Breast Radiotherapy and Systemic Treatments on Regional Recurrence Incidence Among Breast Cancer Patients
por: van Steenhoven, Julia E. C., et al.
Publicado: (2020) -
Omission of axillary sentinel lymph node biopsy in early invasive breast cancer
por: Reimer, Toralf
Publicado: (2023)